37 results on '"Pantano, Serafino"'
Search Results
2. 608 Results of a phase 1 study investigating camidanlumab tesirine as monotherapy and in combination with pembrolizumab in patients with selected advanced solid tumors
3. Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial
4. First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
5. Genome-Wide Expression Profiling of Mid-Gestation Placenta and Embryo Using a 15,000 Mouse Developmental cDNA Microarray
6. CD25, Soluble CD25, and CCL17 As Potential Predictors of Clinical Response to Camidanlumab Tesirine in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma
7. CD19 Expression by IHC Alone Is Not a Predictor of Response to Loncastuximab Tesirine: Results from the LOTIS-2 Clinical Trial and Quantitative Systems Pharmacology Modeling
8. Identification of Predictive Biomarkers for Response of R/R DLBCL Patients Treated with Loncastuximab Tesirine Using Low Pass Whole-Genome Sequencing (WGS)
9. Exploratory Analysis of Factors Influencing Efficacy and Safety of Camidanlumab Tesirine: Data from the Open-Label, Multicenter, Phase 2 Study of Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (R/R cHL)
10. Abstract 4151: Effect of camidanlumab tesirine (Cami) as monotherapy and in combination with pembrolizumab (PEM) on the immune cell profile in patients with selected advanced solid tumors
11. Differential expression of dipeptidyl peptidase IV in human versus cynomolgus monkey skin eccrine sweat glands
12. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma
13. Vascular Origin of Vildagliptin-induced Skin Effects in Cynomolgus Monkeys: Pathomechanistic Role of Peripheral Sympathetic System and Neuropeptide Y
14. Emx2 developmental expression in the primordia of the reproductive and excretory systems
15. Plastic downregulation of the transcriptional repressor BCL6 during maturation of human dendritic cells
16. Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
17. Early and Sustained Circulating Tumor DNA Response Dynamics after Loncastuximab Tesirine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
18. Agenesis of the Scapula in Emx2 Homozygous Mutants
19. Genetic landscape of ALK+ non-small cell lung cancer (NSCLC) patients (pts) and response to ceritinib in ASCEND-1.
20. Urinary clusterin, cystatin C, β2-microglobulin and total protein as markers to detect drug-induced kidney injury
21. Differential Control of Notch1 Gene Transcription by Klf4 and Sp3 Transcription Factors in Normal versus Cancer-Derived Keratinocytes
22. Transcriptome Analysis of Mouse Stem Cells and Early Embryos
23. Modulation of NF-κB Activity by Exchange of Dimers
24. p38-dependent marking of inflammatory genes for increased NF-κB recruitment
25. Two Waves of Nuclear Factor κb Recruitment to Target Promoters
26. PLAC1, an Xq26 Gene with Placenta-Specific Expression
27. Phemx, a Novel Mouse Gene Expressed in Hematopoietic Cells Maps to the Imprinted Cluster on Distal Chromosome 7
28. Gpc3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome
29. Emx 2 developmental expression in the primordia of the reproductive and excretory systems
30. p38-dependent marking of inflammatory genes for increased NF-κB recruitment.
31. Agenesis of the Scapula in Emx2Homozygous Mutants
32. PLAC1,an Xq26 Gene with Placenta-Specific Expression
33. Phemx,a Novel Mouse Gene Expressed in Hematopoietic Cells Maps to the Imprinted Cluster on Distal Chromosome 7
34. <TOGGLE>Gpc3</TOGGLE> expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome
35. In relapsed or refractory diffuse large B-cell lymphoma, CD19 expression by immunohistochemistry alone is not a predictor of response to loncastuximab tesirine.
36. Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury.
37. Modulation of NF-kappaB activity by exchange of dimers.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.